IL-6 Does Not Influence the Expression of SLC41A1 and Other Mg-Homeostatic Factors

Int J Mol Sci. 2024 Dec 11;25(24):13274. doi: 10.3390/ijms252413274.

Abstract

Together with chronic inflammation, disturbed magnesium homeostasis is a factor accompanying chronic disease which thus contributes to a reduced quality of human life. In this study, our objective was to examine the possible IL-6-mediated chronic inflammation-dependent regulation of nine magnesiotropic genes encoding for constituents of magnesium homeostasis of the cell. We used three cell lines (HepG2, U-266, and PANC-1), all characterized by high expression of the IL6R gene and the presence of a membrane form of IL-6R capable of responding to human IL-6. Despite the confirmed activation of the IL-6R/JAK/STAT3 pathway after hIL-6 treatment, we observed no biologically relevant changes in the transcription intensity of the studied magnesiotropic genes. This, however, does not exclude the possibility that IL-6 can affect magnesium homeostasis at levels other than through modified transcription.

Keywords: SLC41A1; STAT3; inflammation; interleukin-6; magnesium.

MeSH terms

  • Cation Transport Proteins* / genetics
  • Cation Transport Proteins* / metabolism
  • Cell Line, Tumor
  • Gene Expression Regulation / drug effects
  • Hep G2 Cells
  • Homeostasis*
  • Humans
  • Interleukin-6* / genetics
  • Interleukin-6* / metabolism
  • Magnesium* / metabolism
  • Receptors, Interleukin-6 / genetics
  • Receptors, Interleukin-6 / metabolism
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction

Substances

  • Interleukin-6
  • Magnesium
  • Cation Transport Proteins
  • SLC41A1 protein, human
  • STAT3 Transcription Factor
  • Receptors, Interleukin-6